المستخلص: |
This study aims to elucidate the current state of the pharmaceutical industry in Algeria by presenting an overview of the pharmaceutical market in Algeria, its advantages, various supporting and interested entities, and its components consisting of specialized pharmaceutical companies. The focus is on two companies within this sector, namely Saidal Group and Biopharm. The study highlights the significant contributions of these companies to the pharmaceutical market in Algeria, providing insights into their reputation and the extent of their trading activities on the Algerian stock exchange. The study concludes that the pharmaceutical industry in Algeria is promising, having made significant strides and achieving self-sufficiency in several drug categories. The ambition persists to achieve complete self sufficiency and reduce the substantial import bill through the concerted efforts of industrial companies, notably Saidal Group and Biopharm. Additionally, governmental efforts are acknowledged for creating a conducive environment for the pharmaceutical market in Algeria and encouraging the active participation of companies within it.
|